Canada markets closed

Gilead Sciences, Inc. (GILD.SN)

Santiago - Santiago Delayed Price. Currency in USD
Add to watchlist
57.39-8.16 (-12.45%)
At close: 11:03AM CLT
Currency in USD

Valuation Measures4

Market Cap (intraday) 80.78B
Enterprise Value 98.50B
Trailing P/E 20.05
Forward P/E 10.07
PEG Ratio (5 yr expected) 0.55
Price/Sales (ttm)3.01
Price/Book (mrq)4.06
Enterprise Value/Revenue 3.59
Enterprise Value/EBITDA 48.26

Trading Information

Stock Price History

Beta (5Y Monthly) 0.20
52-Week Change 30.00%
S&P500 52-Week Change 322.38%
52 Week High 365.55
52 Week Low 357.39
50-Day Moving Average 365.55
200-Day Moving Average 365.55

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 51.25B
Implied Shares Outstanding 61.25B
Float 81.24B
% Held by Insiders 10.09%
% Held by Institutions 188.32%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 33.02
Trailing Annual Dividend Yield 34.61%
5 Year Average Dividend Yield 4N/A
Payout Ratio 488.07%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 14, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 1.77%
Operating Margin (ttm)36.43%

Management Effectiveness

Return on Assets (ttm)10.63%
Return on Equity (ttm)2.39%

Income Statement

Revenue (ttm)27.45B
Revenue Per Share (ttm)22.00
Quarterly Revenue Growth (yoy)5.30%
Gross Profit (ttm)N/A
EBITDA 12.77B
Net Income Avi to Common (ttm)485M
Diluted EPS (ttm)3.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.72B
Total Cash Per Share (mrq)3.79
Total Debt (mrq)25.82B
Total Debt/Equity (mrq)147.93%
Current Ratio (mrq)0.98
Book Value Per Share (mrq)14.01

Cash Flow Statement

Operating Cash Flow (ttm)8.48B
Levered Free Cash Flow (ttm)12.51B